Reply: How well can frailty predict no benefit from ICD therapy?
Key Points:
- Frailty may serve as a significant predictor of limited or no benefit from ICD therapy in elderly or high-risk patients.
- The study examines clinical outcomes, patient characteristics, and the role of frailty assessments in guiding ICD recommendations.
Description
This book explores the predictive value of frailty in determining the lack of benefit from implantable cardioverter defibrillator (ICD) therapy. It critically evaluates existing evidence and discusses implications for patient selection and clinical decision-making.
Be the first to review “Reply: How well can frailty predict no benefit from ICD therapy?”
Reviews
There are no reviews yet.